Decision Support

VisualDx Director of Clinical Impact Dr. Nada Elbuluk discusses Project IMPACT, and how individuals and organizations can work to address gaps in care.

University of Utah Health, Regenstrief Institute and Hitachi this past week announced the development of a new artificial intelligence approach that could help improve treatment for patients with Type 2 diabetes mellitus.

Dave Vennergrund, GDIT vice president of artificial intelligence and data insights, discussed the software's potential to assist in screening patients for possibly harmful diseases.

The cloud-based platform will help drive faster and more efficient research by automating data management, enabling predictive forecasts and more.

The deeper integration of ambient and conversational AI into Millennium will help "streamline workflows while enhancing the essential value of the EHR," said a Nuance leader.

There are still challenges to manage and maturity to build, but machine learning is helping uncover hidden insights and streamline workflows so providers can "use our neurons to take care of patients," said one at HIMSS22.

Dr. Jackie Gerhart, a physician at Epic, sat down at HIMSS22 to discuss the electronic health record's massive research database and how its findings can shape individual services. 

At HIMSS22, the CMIO of BayCare Health System will describe how its clinical and IT staff worked together to ensure care providers "received data exactly how they wanted it to appear" – and reduced prescriptions of controlled substances as a result.

In a preview of his HIMSS22 session, Dr. Thomas Selva talks through his team's Davies Award-winning strategy to detect the life-threatening condition early.